What we know about a new health data tracking system being announced by White House
The collaboration between the federal government and Big Tech would allow patients to more seamlessly track and share their medical records or data among doctors, hospital systems and health apps, the administration and participating companies say.
More details of the system are expected to be announced during a White House event dubbed 'Making Health Technology Great Again' later Wednesday.
Here's how it would work
The system would be maintained by the federal government through the Centers for Medicare and Medicaid Services. Patients will need to opt in to have their medical records and data shared, which CMS says will be kept secure.
Once a patient is in the system, their information could be shared across apps or health systems that have joined the initiative. So, for example, the Apple Health app on your iPhone that tracks your daily step count or your sleep could access lab results from your doctor's office. Putting that information together, the Trump administration says, will offer a fuller picture of your health.
The program could start next year
The U.S. Department of Health and Human Services says that 60 companies have signed on to work with the system and that they have pledged to 'deliver results to the American people in the first quarter of 2026.'
Patient privacy is a top concern
Patient advocates and ethicists say many may worry about how their health information – something Americans have long carefully guarded – could be used in ways that they don't want or expect.
'There are enormous ethical and legal concerns,' said Lawrence Gostin, a Georgetown University law professor who specializes in public health. 'Patients across America should be very worried that their medical records are going to be used in ways that harm them and their families.'
Also, digital privacy advocates say are skeptical that patients will be able to count on their data being stored securely.
'This scheme is an open door for the further use and monetization of sensitive and personal health information,' said Jeffrey Chester at the Center for Digital Democracy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
12 hours ago
- CTV News
U.K. seeks to stamp out ‘cowboy' cosmetic procedures
FILE: A window display advertises low-cost "Brazilian butt lift" cosmetic surgery procedures outside a clinic in the United States on Friday, March 22, 2019. (AP Photo/Ellis Rua, File) The U.K. government on Thursday announced plans to tighten rules on high-risk cosmetic procedures such as so-called Brazilian butt lifts amid a surge in such treatments. The health department said in a statement that 'tough new measures' would 'crack down on cowboy cosmetic procedures that have left people maimed, injured and in need of urgent' care. They include mandating that only qualified health professionals who are registered with the care regulator can carry out procedures like buttock enhancement surgery or the injection of fillers into breasts and genitals. Clinics offering lower risk treatments like Botox and lip fillers would need to meet certain standards to obtain a licence by their local authority, the Department of Health and Social care added. The government said the measures 'follow growing alarm over unqualified individuals performing invasive treatments in unsafe environments -- including homes, hotels, and pop-up clinics'. 'Many of these procedures are marketed as non-surgical but, in reality, are invasive and carry serious risks,' said the health department's statement. The British Association of Aesthetic Plastic Surgeons recorded almost 27,500 surgical procedures in 2024, a five percent increase from the year before. The health department added there had been several incidents where people had received such treatments from providers 'with little or no medical training, leading to dangerous complications, permanent scarring and even death'. Last month, the Chartered Trading Standards Institute warned that fat injections, buttock enhancement surgery, Botox and fillers were being offered by untrained people in places such as public toilets. The Save Face charity said it had supported more than 750 women who have suffered unsafe procedures. Junior health minister Karin Smyth said the proposed measures would give patients 'peace of mind' and reduce the cost to the state-run National Health Service 'of fixing botched procedures'. Under the plans, which will first go to a consultation next year, under 18s will be restricted from cosmetic procedures deemed risky, unless authorised by a health professional. That will prevent children from 'dangerous beauty trends on social media', the department said. The U.K. Health Security Agency (UKHSA) has said 41 people have suffered adverse reactions following cosmetic procedures involving botulinum toxin since early June. Symptoms included difficulty swallowing, slurred speech and breathing problems, the agency said.
Toronto Star
13 hours ago
- Toronto Star
RFK Jr.‘s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement
WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. is vowing to 'fix' the federal program for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by anti-vaccine activists. Health experts and lawyers say updates are needed to help clear a backlog of cases in the Vaccine Injury Compensation Program, created by Congress in 1986 as a no-fault payment system for presumed vaccine injuries.
Ottawa Citizen
13 hours ago
- Ottawa Citizen
Adam: Even now, the PSA test remains highly controversial
Article content I've been thinking about writing this column for about five years, but haven't done so until now because there is a personal element to it. But former U.S. president Joe Biden's recent prostate cancer diagnosis finally pushed me over the line. Article content I don't want to be overly dramatic about it, but it is something of a Shakesperean dilemma: to do or not to do a PSA test for prostate cancer. Article content Article content Article content Research published in 2006 in the Canadian Journal of Public Health (the latest definitive data I could find) showed that 47.5 per cent of Canadian men over 50 had taken a PSA test for prostate cancer in their lifetime. I am one of the 52.5 per cent who haven't done so. A more recent report on American adults issued in 2023 by the U.S. National Cancer Institute, said 38 per cent of men had had a PSA test for prostate cancer within the past year, in that case 2023. Article content My inclination is to take the test, but my family doctor cautions against it, because it doesn't definitively tell whether you have prostate cancer, and after testing and possible treatment, the potential for harm is considerable. Even if the test detects cancer, the disease may never bother you. The psychological and physical damage that may ensue after a test can be devastating, he says. However, my doctor says that if I insist, he'll arrange it, but to help me understand the full implications, he referred me to a report on the subject by the Canadian Task Force on Preventive Health (CTFPHC). I didn't know about the study, but the findings are sobering. They vindicated my doctor's advice. If you haven't read the report, do so. Article content Article content The CTFPHC is an independent, expert federal body charged with developing national preventive health guidelines for primary care. It examined what would happen if 1,000 men aged 55 to 69 were screened over a 13-year period, and the recommendation was surprising. 'The Canadian Task Force on Preventive Health recommends against screening for prostate cancer with the PSA test,' it says. The task force says 'the potential small benefit' from PSA screening is 'outweighed' by 'the potential significant harms of the screening and associated follow-up treatment.' Article content It says that if 1,000 men are screened with PSA, the risk of dying from prostate cancer is five in a 1,000. And among those who are not screened with PSA, the risk of dying from prostate cancer is six in 1,000. Basically, there's little difference in mortality rates. Of the 1,000 men screened, 720 will have a negative test. One hundred and seventy-eight, or almost 20 per cent, will have 'false positives' that will require unnecessary biopsies. One hundred and two men will be diagnosed with prostate cancer, but 33, or about one-third of these diagnoses, will not result in symptoms or death in the patient's lifetime. But, because of uncertainty about the progression of the disease, these men will likely seek treatment.
